Mapping the Druggable Allosteric Space of G‐Protein Coupled Receptors: a Fragment‐Based Molecular Dynamics Approach
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
To address the problem of specificity in G‐protein coupled receptor (GPCR) drug discovery, there has been tremendous recent interest in allosteric drugs that bind at sites topographically distinct from the orthosteric site. Unfortunately, structure‐based drug design of allosteric GPCR ligands has been frustrated by the paucity of structural data for allosteric binding sites, making a strong case for predictive computational methods. In this work, we map the surfaces of the β 1 (β 1 AR) and β 2 (β 2 AR) adrenergic receptor structures to detect a series of five potentially druggable allosteric sites. We employ the FTMAP algorithm to identify ‘hot spots’ with affinity for a variety of organic probe molecules corresponding to drug fragments. Our work is distinguished by an ensemble‐based approach, whereby we map diverse receptor conformations taken from molecular dynamics (MD) simulations totaling approximately 0.5 μs. Our results reveal distinct pockets formed at both solvent‐exposed and lipid‐exposed cavities, which we interpret in light of experimental data and which may constitute novel targets for GPCR drug discovery. This mapping data can now serve to drive a combination of fragment‐based and virtual screening approaches for the discovery of small molecules that bind at these sites and which may offer highly selective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · cited 1×
“Testament to this, GPCRs are associated with approximately 30% of current drugs (4) and are linked to such diseases as cancer (5) and those of the cardiovascular and central nervous systems (6,7).”
BackgroundAllosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Crystal structure of opsin in its G-protein-interacting conformation
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059
Implications of protein flexibility for drug discovery
Teague, S. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1129 · Cited by 755 · cited 1×
“Considering the structural flexibility of proteins, this static representation of the target can be extremely restrictive and is a recognized flaw in many protein– ligand docking efforts (45,46).”
BackgroundFlexible ligand docking to multiple receptor conformations: a practical alternative
Totrov, M., & Abagyan, R. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.01.004 · Cited by 497 · cited 1×
“Consequently, a variety of schemes have been proposed that allow target flexibility to be taken into account and range from modeling simple sidechain changes to full backbone and sidechain mobility (47,48).”
BackgroundCoarse-Grained MD Simulations of Membrane Protein-Bilayer Self-Assembly
Scott, K. A., Bond, P. J., Ivetac, A., Chetwynd, A. P., Khalid, S., & Sansom, M. S. P. (2008) · Structure · doi:10.1016/j.str.2008.01.014 · Cited by 207
Self-citation
Cited by
Molecular dynamics simulations and drug discovery
Durrant, J. D., & McCammon, J. A. (2011) · BMC Biology · doi:10.1186/1741-7007-9-71 · Cited by 1,403
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 671
Kozakov, D., Grove, L. E., Hall, D. R., Bohnuud, T., Mottarella, S. E., Luo, L., Xia, B., Beglov, D., & Vajda, S. (2015) · Nature Protocols · doi:10.1038/nprot.2015.043 · Cited by 648
Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways
Kohlhoff, K. J., Shukla, D., Lawrenz, M., Bowman, G. R., Konerding, D. E., Belov, D., Altman, R. B., & Pande, V. S. (2014) · Nature Chemistry · doi:10.1038/nchem.1821 · Cited by 416
Molecular modeling in drug discovery
Adelusi, T. I., Oyedele, A.-Q. K., Boyenle, I. D., Ogunlana, A. T., Adeyemi, R. O., Ukachi, C. D., Idris, M. O., Olaoba, O. T., Adedotun, I. O., Kolawole, O. E., et al. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100880 · Cited by 387
Metadata
- Authors
- Ivetac, A., & Andrew McCammon, J.
- Venue
- Chemical Biology & Drug Design
- Publisher
- Wiley
- Published
- 2010-08-02
- Volume
- 76
- Issue
- 3
- Pages
- 201-217
- ISSN
- 1747-0277 (ISSN-L)
- 1747-0285
- OpenAlex
- W1722748669
- Cited by
- 112
- References
- 6
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mapping the Druggable Allosteric Space of G‐Protein Coupled Receptors: a Fragment‐Based Molecular Dynamics Approach. https://app.cochat.ai/papers/10.1111/j.1747-0285.2010.01012.x
- The paper
- Ivetac, A., & Andrew McCammon, J. (2010). Mapping the Druggable Allosteric Space of G‐Protein Coupled Receptors: a Fragment‐Based Molecular Dynamics Approach. Chemical Biology & Drug Design. https://doi.org/10.1111/j.1747-0285.2010.01012.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.